Accueil
Détail de l'auteur
Documents disponibles écrits par cet auteur (350)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Rapport
OEDT = EMCDDA ; V. AUWÄRTER ; J. DE MORAIS ; A. GALLEGOS ; M. EVANS-BROWN ; R. CHRISTIE ; R. JORGE ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Technical reports | 2021This report provides a technical review of the current body of knowledge regarding synthetic cannabinoids that are monitored by the EU Early Warning System. The aim of this report is to strengthen situational awareness of synthetic cannabinoids [...]Rapport
OEDT = EMCDDA ; European Centre for Disease Prevention and Control | Lisbon : OEDT / EMCDDA | Joint publications | 2017A higher prevalence of communicable diseases among people in prison compared with the general public is recognised as a public health issue as well as a major concern for the people affected, as the majority of incarcerated people return to thei[...]Rapport
OEDT = EMCDDA ; European Centre for Disease Prevention and Control | Lisbon : OEDT / EMCDDA | Joint publications | 2018Compared with the general public, people in prisons have a higher prevalence of infection with blood-borne viruses (BBVs) such as human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV). This is recognised as a ma[...]Rapport
Use of the internet has changed drug dealing over the past decade. While there is a growing understanding of the role of darknet drug markets, little is known about how drug dealing works on public online services such as social media. This stud[...]Rapport
Despite much speculation and conjecture over potential crossovers between terrorists and the drug trade in Europe, no study has examined the issue. This paper fills this gap by empirically examining such crossovers in the European Union between [...]Rapport
ENGLISH: Patterns of drug use and developments in the drug market in Europe are becoming more complex and dynamic, with major implications for drug monitoring and research. This observation prompted the European Monitoring Centre for Drugs and [...]Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; A. BO ; A. OTEO | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2016FRANÇAIS : Comment fonctionnent les marchés des drogues en ligne ? Quelles technologies utilisent-ils ? Quelles relations entretiennent-ils avec le marché traditionnel des drogues ? Comment peuvent-ils être surveillés et contrôlés ? Depuis u[...]Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; A. BO ; D. KLEMPOVA ; A. OTEO ; L. VANDAM | Lisbon : OEDT / EMCDDA | Technical reports | 2015The speed with which the Internet is transforming drug markets poses a major challenge to law enforcement, public health, research and monitoring agencies. This study aims to raise understanding of the current online supply of drugs and to map t[...]Rapport
OEDT = EMCDDA ; K. SKARUPOVA | Lisbon : OEDT / EMCDDA | EMCDDA Literature reviews, ISSN 1725-0579 | 2014This report presents the findings of a literature review to identify the most frequently occurring patterns of use and their relation to harm in users of opioids, powder and crack cocaine, and meth/amphetamine. The behavioural factors that were [...]Brochure
This information brochure has been produced by the EMCDDA to provide answers to the most commonly asked questions on the Reitox network of national focal points and more broadly on national drugs observatories. Compiled over several years, it is[...]Rapport
This report marks the end of a preparatory phase of work and, in the future, data from the acceding and candidate central and east European countries will form part of the overall picture of drug use in the European Union. Where possible, data f[...]Rapport
OEDT = EMCDDA ; W. VANDERPLASSCHEN ; S. VANDEVELDE ; E. BROEKAERT | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2014Therapeutic communities first developed in the 1960s and have continuing relevance in the world of drug treatment today. This report presents how therapeutic communities have developed over time, with reference to seven European countries, and p[...]Rapport
This publication presents the data and findings of the risk assessment on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2-carboxamide (THF-F), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017. In March 20[...]Rapport
FRANÇAIS : La volonté politique confirmée de répondre au problème des drogues en Europe ne se traduit pas seulement par l'élaboration de politiques adéquates, elle se reflète également dans les fonds publics alloués à leur mise en œuvre. Le pl[...]Chapitre
FRANÇAIS : Dans le plan d'action antidrogue de l'UE (2000-2004), le troisième objectif stratégique consiste à «augmenter de manière significative le nombre de toxicomanes traités avec succès». Malgré l'absence de données cumulées à l'échelle eu[...]